US BANCORP \DE\ - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 94 filers reported holding VBI VACCINES INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of VBI VACCINES INC
ValueSharesWeighting
Q4 2022$16400.0%0.00%
Q3 2022$0400.0%0.00%
Q2 2022$0400.0%0.00%
Q1 2022$0400.0%0.00%
Q4 2021$0400.0%0.00%
Q3 2021$0400.0%0.00%
Q2 2021$0400.0%0.00%
Q1 2021$040
-50.0%
0.00%
Q4 2020$0800.0%0.00%
Q3 2020$0
-100.0%
80
-94.7%
0.00%
Q2 2020$5,000
-72.2%
1,520
-91.9%
0.00%
Q1 2020$18,000
+12.5%
18,773
+63.4%
0.00%
Q4 2019$16,00011,4910.00%
Other shareholders
VBI VACCINES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$171,182,0002.49%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$5,839,0000.50%
HighVista Strategies LLC 41,271$129,0000.08%
ArchPoint Investors 65,000$202,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 136,714$425,0000.06%
FNY Investment Advisers, LLC 24,683$76,0000.04%
GRIMES & COMPANY, INC. 257,960$802,0000.04%
Cambridge Investment Research Advisors, Inc. 2,065,953$6,425,0000.03%
Ergoteles LLC 171,127$532,0000.02%
J.W. COLE ADVISORS, INC. 71,100$221,0000.02%
View complete list of VBI VACCINES INC shareholders